Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Varex Imaging (VREX) EBITDA (2016 - 2026)

Historic EBITDA for Varex Imaging (VREX) over the last 11 years, with Q1 2026 value amounting to $15.4 million.

  • Varex Imaging's EBITDA rose 3750.0% to $15.4 million in Q1 2026 from the same period last year, while for Jan 2026 it was -$23.6 million, marking a year-over-year decrease of 16035.81%. This contributed to the annual value of -$27.8 million for FY2025, which is 18660.44% down from last year.
  • Latest data reveals that Varex Imaging reported EBITDA of $15.4 million as of Q1 2026, which was up 3750.0% from $19.6 million recorded in Q4 2025.
  • Over the past 5 years, Varex Imaging's EBITDA peaked at $26.6 million during Q2 2022, and registered a low of -$80.7 million during Q3 2025.
  • Over the past 5 years, Varex Imaging's median EBITDA value was $15.5 million (recorded in 2023), while the average stood at $10.7 million.
  • The largest annual percentage gain for Varex Imaging's EBITDA in the last 5 years was 18701.3% (2025), contrasted with its biggest fall of 96774.19% (2025).
  • Over the past 5 years, Varex Imaging's EBITDA (Quarter) stood at $13.0 million in 2022, then crashed by 67.69% to $4.2 million in 2023, then surged by 159.52% to $10.9 million in 2024, then skyrocketed by 79.82% to $19.6 million in 2025, then fell by 21.43% to $15.4 million in 2026.
  • Its EBITDA was $15.4 million in Q1 2026, compared to $19.6 million in Q4 2025 and -$80.7 million in Q3 2025.